identifi
good
start
point
modif
lead
effici
bioavail
inhibitor
sar
coronaviru
main
proteinas
sarscov
pro
synthesi
intermedi
analogu
proceed
via
highli
diastereoselect
indiummedi
allyl
aaminoaldehyd
sever
acut
respiratori
syndrom
sar
first
report
asia
februari
month
diseas
spread
like
origin
southern
china
two
dozen
countri
north
america
south
america
europ
asia
case
infect
sar
character
high
fever
malais
rigor
headach
nonproduct
cough
dyspnoea
may
progress
gener
interstiti
infiltr
lung
fatal
rate
among
peopl
ill
around
calcul
death
death
surviv
patient
novel
coronaviru
identifi
caus
agent
sar
order
find
effici
therapi
sar
mani
scientist
focus
develop
drug
inhibit
viral
main
proteinas
sarscov
pro
disrupt
replic
cycl
viru
may
hilgenfeld
cowork
show
substratebind
site
sarscov
pro
well
conserv
compar
two
coronaviru
main
proteinas
hcov
tgev
pro
addit
report
similar
substrateinhibitorbind
mode
sarscov
pro
distantli
relat
human
rhinoviru
proteinas
hrv
pro
base
find
suggest
hrv
pro
inhibitor
could
serv
good
start
point
modif
lead
effici
bioavail
inhibitor
sarscov
pro
coronaviru
main
proteinas
current
clinic
trial
treatment
caus
hrv
scheme
retrosynthet
analysi
led
us
two
key
intermedi
lacton
lactam
synthesi
group
proceed
via
highli
stereoselect
indiummedi
allyl
reaction
nprotect
valin
illustr
scheme
although
synthes
fragment
similar
previous
report
synthet
strategi
present
herein
two
major
advantag
firstli
incorpor
group
first
step
synthesi
increas
effici
away
protect
deprotect
amino
group
addit
synthet
strategi
easili
allow
us
make
modif
hilgenfeld
cowork
suggest
part
could
accommod
activ
site
sarscov
pro
base
molecular
model
pfluorobenzyl
group
might
long
fit
pocket
synthesi
pfluorobenzyl
group
introduc
final
step
allow
us
gener
analogu
simpli
chang
organocupr
reagent
employ
lacton
synthes
six
step
l
lvalin
methyl
ester
hydrochlorid
hydrochlorid
salt
first
coupl
acid
give
methyl
ester
almost
quantit
yield
subsequ
nabh
reduct
thf
methanol
afford
baminoalcohol
yield
alcohol
oxid
aaminoaldehyd
swern
condit
aaminoaldehyd
particularli
prone
epimer
purif
perform
instead
crude
product
swern
oxid
use
directli
subsequ
indiummedi
allyl
reaction
thu
crude
aldehyd
react
methyl
bromomethyl
acryl
presenc
indium
metal
furnish
homoallyl
alcohol
overal
yield
almost
complet
syn
diastereoselect
synanti
unusu
high
diastereoselect
indiummedi
allyl
might
explain
base
felkinanh
chelat
model
shown
scheme
anitrogen
atom
coordin
indium
metal
form
fivememb
chelat
ring
see
transit
state
lead
antiisom
pronounc
steric
repuls
ipropyl
group
r
group
axial
posit
r
coom
result
synisom
favour
howev
report
steurer
podlech
aamino
group
protect
use
benzyloxycarbonyl
cbz
indiummedi
allyl
correspond
l
lvalin
gave
synanti
diastereoisomer
ratio
addit
perform
indiummedi
allyl
reaction
ntbutyloxycarbonyl
lvalin
obtain
homoallyl
alcohol
mixtur
synanti
isom
scheme
clearli
chelat
anitrogen
atom
steric
bulki
ipropyl
group
total
account
observ
select
reaction
suggest
isoxazol
group
could
involv
therefor
propos
nitrogen
atom
isoxazol
ring
coordin
indium
atom
form
second
fivememb
chelat
ring
scheme
interact
isoxazol
ring
indium
metal
caus
transit
state
rigid
compar
scheme
less
pucker
transit
state
r
isoxazol
possibl
compar
r
cbz
boc
minim
steric
repuls
ipropyl
group
coom
group
transit
state
lead
anti
product
therefor
destabil
result
increas
synanti
select
respect
synthesi
l
lleucin
analogu
lacton
improv
synanti
select
also
clearli
demonstr
scheme
excel
diastereoselect
allyl
step
make
synthet
strategi
effici
pave
way
control
second
stereogen
centr
molecul
upon
accomplish
critic
step
homoallyl
alcohol
cycliz
use
ptoluenesulfon
acid
dichloromethan
afford
bunsatur
lacton
high
yield
scheme
conjug
addit
organocupr
reagent
form
situ
pfluorobenzylmagnesium
bromid
copper
cyanid
final
provid
key
intermedi
lacton
yield
mixtur
isom
cistran
desir
transisom
obtain
major
product
confirm
noe
experi
herein
report
asymmetr
synthesi
key
intermedi
synthet
approach
toward
analogu
critic
step
synthesi
involv
highli
diastereoselect
indiummedi
allyl
reaction
synthes
second
key
intermedi
analogu
underway
laboratori
compound
obtain
test
examin
inhibitori
abil
replic
spread
sar
coronaviru
